Abbott Laboratories is discussing the acquisition of Synlait's Pokeno facility and considering other facilities in New Zealand.
2 reports, 2 independent
Updated Aug 17
Gone quiet
- Reports
- 2
- Developments
- 3
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Abbott Laboratories is discussing the acquisition of Synlait's Pokeno facility and considering other facilities in New Zealand.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Synlait sold its North Island assets to Abbott Laboratories, whose base operations are in the New Zealand market.1 source
- An article details how the company Synlait operates in New Zealand, including its assets and majority shareholder structure.Sub-event
Abbott is exploring the acquisition of Synlait's facility in New Zealand.1 source
Keep exploring
The entities involved
-
Abbott Laboratories
American global health care and medical device products company
-
Synlait
New Zealand dairy processing company
Nothing else this week.
Coverage
Newest first; wire copies grouped- yahoo.com
- Simply Wall St.Abbott’s Possible Pokeno Acquisition Might Change the Case for Investing in Abbott Laboratories (ABT) In August 2025, it was reported that Abbott Laboratories was in discussions with Synlait Milk Lim